This clinical trial, sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine, investigates the effects of an anti-inflammatory diet on patients with IBD. The study is currently recruiting participants and aims to validate a novel dietary intervention that could enhance patient quality of life and reduce inflammatory markers. If successful, this could position AID as a complementary treatment strategy in the management of IBD, potentially appealing to a growing market of patients seeking non-pharmacological interventions. The competitive landscape includes existing dietary management strategies, but the unique focus on a structured AID program and its integration with a digital application may provide a differentiated offering. Diligence considerations should include the scalability of the intervention and potential partnerships with digital health platforms.